You talk smart, but common sense says that they are making deals at a better rate. First deal with Midam when we were in subpennies and with significant debt - 20 million shares. Last deal 3 million shares. That's like 85 % less shares than they received just a year ago. Secondly, Chicago Ventures deal is for $0.05 a share if conversion occurs. That is the cheapest they can exchange the balance on the LOC for. Let's just hypothetically say RXMD doesn't pay back the $280k owed. To convert, Chicago Ventures would get 5.6 million shares (280,000/.05) Yet if the deal was struck at just market value at today's share price they would have received 9.3 million shares (280,000/.03) Despite what some have characterized as poor management. They are doing just as they should be, offering far less shares for services due to company's growing value. Now Midam needs to do the same or beat it.